Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features

被引:71
作者
De Moliner, L [1 ]
Pontisso, P [1 ]
De Salvo, GL [1 ]
Cavalletto, L [1 ]
Chemello, L [1 ]
Alberti, A [1 ]
机构
[1] Univ Padua, Dipartimento Med Clin & Sperimentale, Clin Med 5, I-35128 Padua, Italy
关键词
HCV RNA; bDNA assay; liver disease activity;
D O I
10.1136/gut.42.6.856
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background-Liver disease in chronic hepatitis C virus (HCV) infection ranges from minimal lesions to Liver cirrhosis, eventually evolving to hepatocellular carcinoma. Whether and how HCV determines the different clinical and histological manifestations of the disease is not fully understood. Aims-To verify whether the amount of virus in individual patients could be related to the severity of liver injury. Patients and methods-Levels of HCV RNA were measured in serum in 96 consecutive patients with chronic hepatitis type C using a signal amplification assay. The relation between viraemic values and the corresponding viral load in the liver was assessed in a subgroup of 21 patients in whom HCV RNA was measured in serum samples and liver specimens obtained at the same time. Results-A positive correlation was observed between the amount of viral nucleic acid in the two compartments, indicating that levels of viraemia reflect the amount of virus present in the liver. Viral load did not correlate with aminotransferase activities nor with histological diagnosis, and serum and liver levels of HCV RNA were not significantly different in patients infected by the various HCV genotypes. Conclusions-Measurement of HCV replication in serum is a mirror of viral replication in the liver. The extent of replicative activity of HCV does not seem to play a role in the modulation of the associated hepatic disease.
引用
收藏
页码:856 / 860
页数:5
相关论文
共 35 条
[1]
IMMUNOLOGICAL AND MOLECULAR-BASIS OF VIRAL PERSISTENCE - THE HEPATITIS-B VIRUS MODEL [J].
BARNABA, V ;
BALSANO, F .
JOURNAL OF HEPATOLOGY, 1992, 14 (2-3) :391-400
[2]
PERSISTENT HEPATITIS-C VIREMIA WITHOUT LIVER-DISEASE [J].
BRILLANTI, S ;
FOLI, M ;
GAIANI, S ;
MASCI, C ;
MIGLIOLI, M ;
BARBARA, L .
LANCET, 1993, 341 (8843) :464-465
[3]
CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF [J].
CERNY, A ;
MCHUTCHISON, JG ;
PASQUINELLI, C ;
BROWN, ME ;
BROTHERS, MA ;
GRABSCHEID, B ;
FOWLER, P ;
HOUGHTON, M ;
CHISARI, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :521-530
[4]
Chayama K, 1993, J GASTROEN HEPATOL, V8, pS40
[5]
COELHOLITTLE E, 1995, J HEPATOL, V22, P508
[6]
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[7]
FERRARI C, 1994, HEPATOLOGY, V19, P286
[8]
FRANCESCONI R, 1995, ITAL J GASTROENTEROL, V27, P213
[9]
ASSESSMENT OF HEPATITIS-C VIRUS-RNA LEVELS BY QUANTITATIVE COMPETITIVE RNA-POLYMERASE CHAIN-REACTION - HIGH-TITER VIREMIA CORRELATES WITH ADVANCED-STAGE OF DISEASE [J].
GRETCH, D ;
COREY, L ;
WILSON, J ;
DELAROSA, C ;
WILLSON, R ;
CARITHERS, R ;
BUSCH, M ;
HART, J ;
SAYERS, R ;
HAN, J .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) :1219-1225
[10]
ASSESSMENT OF HEPATITIS-C VIREMIA USING MOLECULAR AMPLIFICATION TECHNOLOGIES - CORRELATIONS AND CLINICAL IMPLICATIONS [J].
GRETCH, DR ;
DELAROSA, C ;
CARITHERS, RL ;
WILLSON, RA ;
WILLIAMS, B ;
COREY, L .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (05) :321-329